Developer docs
API playgroundTry for free, no card

Search company profiles

Medisafe

Full company profile

uuid00007o3

Namestring
Medisafe
Legal namestring
Medisafe Project Ltd.
Websiteurl
medisafe.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Medisafe, founded in 2012 and headquartered in Needham, Massachusetts (with R&D in Israel), is a private AI-driven patient engagement platform purpose-built for the pharmaceutical industry. The company combines behavioral science, machine learning, and omnichannel delivery to help pharmaceutical companies improve medication adherence and persistence across their drug portfolios. Its core technology architecture centers on the proprietary JITI (Just-in-Time Interventions) predictive engine, which is trained on 12+ years of real-world adherence data across 13M+ IQVIA-validated patients and analyzes 130+ behavioral signals per patient to predict non-adherence risk and trigger personalized interventions. The platform is delivered to pharmaceutical companies through Medisafe Maestro, an enterprise orchestration tool that enables pharma teams to design, deploy, and manage personalized patient journeys across brands and markets, complemented by therapy-specific branded Digital Drug Companions, a PATHWAYS web-based care coordination platform for providers, and an AI Voice Agent (VIA) for phone-based patient engagement.

The company generates revenue primarily through multi-year enterprise SaaS subscriptions with pharmaceutical companies for branded digital drug companion deployments, with pricing tied to deployment scope, number of brands, markets, and patient volume. The customer base includes 25+ pharma partners drawn from the top 20 global pharmaceutical companies across therapeutic areas including immunology, inflammatory conditions, mental health, metabolic/GLP-1, neurology, and oncology. A free consumer-facing Medisafe mobile app (4.7-star rating, 150K+ app-store reviews) functions as a freemium acquisition channel and distribution surface for pharma partner programs. Professional services revenue from implementation, configuration, and integration with pharma PSPs and hub services supplements the subscription base. Distribution combines direct enterprise field sales to pharma brand teams and procurement, white-label/OEM licensing through the Maestro SDK, and consumer self-serve app store downloads.

Medisafe's platform is validated through peer-reviewed research with IQVIA, Komodo Health, Vanderbilt University/NIH, and JMIR, and the company holds ISO 27001, ISO 13485 (enabling Software as a Medical Device positioning), HIPAA, SOC 2 Type II, GDPR, and 21 CFR Part 11 certifications. Strategic pharma co-development is anchored by partnerships with Eisai and Biogen on the PATHWAYS platform for Alzheimer's disease patient management, and the company maintains a strategic technology partnership with Amazon Web Services (AWS) for AI infrastructure. Institutional investors include ALIVE Israel HealthTech Fund (lead Series C, board seat), Sanofi Ventures (board seat), Pitango Venture Capital (board seat), Octopus Ventures, 7wire Ventures, Qualcomm Ventures, and M Ventures, with total disclosed funding of approximately $51.5M across rounds from 2012 through 2021.

Short descriptiontext

Medisafe is an AI-driven patient engagement platform that helps pharmaceutical companies improve medication adherence through branded digital drug companions, predictive behavioral interventions, and provider care coordination tools, serving 25+ top-20 global pharma partners across 150+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medication adherence software, patient engagement platform, digital therapeutics, pharma patient support, healthcare analytics
Industry3 codes
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAHAD
Care Management & Coordination Platforms (case/disease management workflows)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Patient Engagement Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise SaaS Platform Licensing
TypeSubscription Recurring
Description

Pharmaceutical companies license the Medisafe platform to deploy branded digital drug companions for their therapies. Pricing is based on deployment scope, number of brands, markets, and patient volume.

medisafe.com
2Patient App (Freemium)
TypeFreemium
Description

Free medication management app for consumers with premium features available. The app serves as a distribution channel for pharma partner programs and generates indirect revenue through B2B relationships.

medisafe.com
3Professional Services
TypeProfessional Services
Description

Implementation, configuration, and customization services for pharma partners deploying branded experiences. Includes onboarding, integration with existing hub/PSP programs, and ongoing support.

medisafe.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details3 tiers
1Patient App - Free Tier
ModelFreemiumBilling cadenceOthers
Notes

Core medication management features including reminders, drug interaction alerts, progress reports, and caregiver support available at no cost.

medisafe.com
2Enterprise Pharma Platform
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom enterprise pricing based on portfolio size, number of brands, markets deployed, and patient volume. Not publicly disclosed.

medisafe.com
3PATHWAYS for Healthcare Providers
ModelFreemiumBilling cadenceOthers
Notes

Complimentary web-based tool for HCPs, infusion centers, and clinical teams managing chronic disease patients.

medisafe.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1JITI (Just-in-Time Intervention)
Description

Proprietary AI-driven behavioral prediction engine that identifies patient non-adherence risk and triggers personalized just-in-time interventions.

medisafe.com
+4 more records
Core offering1 text field

Medisafe operates a behavior-driven patient engagement platform combining the Medisafe Maestro enterprise orchestration suite, the JITI predictive AI engine, and therapy-specific Digital Drug Companions that pharmaceutical companies license to deploy branded patient support across brands and markets. The platform is complemented by a free consumer mobile app for medication management, the PATHWAYS web-based care coordination tool for healthcare providers, and an AI Voice Agent (VIA) for conversational patient outreach.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 15% increase in medication adherence
+8 more records
Product overview1 text field

Medisafe is a modular patient engagement platform architecture consisting of three core engines: Medisafe Maestro (enterprise orchestration platform for pharma teams), Digital Drug Companion (therapy-specific patient experiences), and JITI Predictive Engine (behavioral intelligence layer). The platform serves pharmaceutical companies, healthcare providers, and patients directly, offering solutions for Hub & PSP acceleration, drug launch support, portfolio-wide orchestration, and clinical trial support. Additional offerings include the Medisafe consumer app for medication management, AI Voice Agent (VIA) for conversational support, and PATHWAYS for provider care coordination. The platform is validated through IQVIA, Vanderbilt University, NIH, and Komodo Health research.

Product and service6 records
1Medisafe Maestro
CategoryEnterprise Platform
Description

Enterprise orchestration platform serving as the command center for pharma patient engagement programs. Enables pharmaceutical brand teams to design, deploy, and manage personalized patient journeys across brands and markets without engineering resources, with visual journey builder, multi-brand/multi-market campaign management, real-time analytics, configurable intervention rules, and enterprise SSO/audit logging.

2Digital Drug Companion
CategoryPatient Engagement Solution
Description

Therapy-specific branded patient experiences that extend pharmaceutical support beyond the prescription, tailored to each therapy's adherence challenges, side-effect profile, and patient population. Includes personalized medication reminders, therapy-specific education, caregiver coordination, progress tracking, white-label branding, and omnichannel engagement across web, app, text, and voice.

3JITI Predictive Engine
CategoryAI Engine
Description

Behavioral intelligence layer built on 12+ years of real-world patient data that uses machine learning to predict patient risk and trigger just-in-time interventions. Features predictive non-adherence risk scoring, intervention triggers based on 130+ behavioral signals per patient, personalization engine, continuous learning, and privacy-first architecture with de-identified behavioral models.

4Medisafe App
CategoryConsumer Mobile App
Description

Free medication management mobile app helping millions of patients track medications, appointments, and measurements. Features smart reminders, drug interaction alerts, caregiver support via Medfriend, progress reports, and integration with Apple HealthKit, Samsung S-Health, and Google Fit.

5PATHWAYS
CategoryCare Coordination Platform
Description

Web-based care coordination platform for healthcare providers, HCPs, infusion centers, and clinical teams managing patients on chronic and specialty therapies. Offers at-a-glance patient and disease care dashboards, multi-site care coordination, and care plan tracking, recognized as Best Care Coordination Platform in 2025 MedTech Breakthrough Awards.

6Medisafe AI Voice Agent (VIA)
CategoryVoice AI Module
Description

Conversational AI voice agent that proactively engages patients via phone to log doses, check symptoms, and deliver personalized support. Extends reach across digital literacy levels and age groups, especially for populations less engaged with apps or digital interfaces.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership announced in 2023 combining Medisafe's 10+ years of healthcare data and experience with AWS's AI capabilities to build the future of connected health with technology advancements and regulatory achievements.

Strategic tierCoreTypeTechnology or Integration
Description

Open APIs enable integration with Electronic Health Records, CRM systems, and pharma's existing digital infrastructures for seamless patient journeys and consistent brand experience.

3Eisai
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-developed PATHWAYS platform for Alzheimer's disease patient care coordination. Eisai and Biogen partnered with Medisafe to deploy the web-based tool for FDA-approved monoclonal antibody treatments.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-developed PATHWAYS platform for Alzheimer's disease patient care coordination. PATHWAYS is recognized as Best Care Coordination Platform in 2025 MedTech Breakthrough Awards.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership conducting validation studies on medication adherence. IQVIA published peer-reviewed research demonstrating Medisafe's impact on HIV and hypertension patient adherence outcomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare data partnership for real-world evidence. Komodo Health study of 1600 patients over 52 weeks demonstrated 22% incremental persistence lift and 2.1 additional Rxs per patient for Medisafe users.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership contributing to NIH-published research validating Medisafe's platform efficacy and patient outcomes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Digital health platform focused on chronic disease management with FDA-cleared SaMD products and pharma partnerships (e.g., AstraZeneca). Operates a similar B2B2C model serving payers, providers, and pharma — directly comparable to Medisafe's Maestro + JITI architecture.

TypeDirect peer
Description

Prescription digital therapeutics company with pharma partnerships (Otsuka for depression adjunct, Boehringer Ingelheim). Pursues the same enterprise pharma licensing model and FDA-regulated digital therapeutic pathway that Medisafe targets via ISO 13485 SaMD positioning.

TypeDirect peer
Description

Medication adherence management platform combining predictive analytics with human outreach for payers, health systems, and pharma. Competes with Medisafe on the payer-sponsored adherence layer and predictive non-adherence risk scoring use case.

TypeDirect peer
Description

Medication adherence analytics platform using predictive models to identify at-risk patients for payers and PBMs. Overlaps with Medisafe's JITI predictive engine and pharma/payer GTM motion.

TypeDirect peer
Description

Digital medication adherence platform featuring directly observed therapy via video and asynchronous chat. Competes with Medisafe's patient engagement offering, particularly in public health, infectious disease, and specialty therapy adherence.

TypeDirect peer
Description

Provider-patient engagement and messaging platform that connects pharma brand messaging into the EHR workflow. Targets the same pharma brand team buyers as Medisafe and represents a competing approach to in-workflow digital engagement.

TypeDirect peer
Description

Digital therapeutics company with FDA-cleared prescription cognitive treatments, monetized via consumer subscription and potential pharma channels. Operates in the adjacent digital therapeutics category with the same pharma-licensing thesis.

TypeEmerging player
Description

Digital health company focused on metabolic disease reversal (type 2 diabetes, prediabetes) with strong outcomes evidence and payer/employer contracts. Overlaps with Medisafe in the metabolic/GLP-1 therapeutic area and chronic-condition patient engagement.

TypeEmerging player
Description

Virtual-first chronic care platform for diabetes, hypertension, and mental health sold primarily to employers and payers. Overlaps with Medisafe in chronic-condition management and GLP-1/musculoskeletal therapeutic engagement.

TypeBroad incumbent
Description

Pharma commercial cloud platform offering CRM, content management, and patient engagement modules. Represents the larger incumbent that pharma procurement may consolidate toward, potentially squeezing specialized vendors like Medisafe into narrower niches.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medisafe

Pharmaceutical Patient Engagement Softwaremedisafe.com

Medisafe is an AI-driven patient engagement platform that helps pharmaceutical companies improve medication adherence through branded digital drug companions, predictive behavioral interventions, and provider care coordination tools, serving 25+ top-20 global pharma partners across 150+ countries.

What Medisafe does

Medisafe, founded in 2012 and headquartered in Needham, Massachusetts (with R&D in Israel), is a private AI-driven patient engagement platform purpose-built for the pharmaceutical industry. The company combines behavioral science, machine learning, and omnichannel delivery to help pharmaceutical companies improve medication adherence and persistence across their drug portfolios. Its core technology architecture centers on the proprietary JITI (Just-in-Time Interventions) predictive engine, which is trained on 12+ years of real-world adherence data across 13M+ IQVIA-validated patients and analyzes 130+ behavioral signals per patient to predict non-adherence risk and trigger personalized interventions. The platform is delivered to pharmaceutical companies through Medisafe Maestro, an enterprise orchestration tool that enables pharma teams to design, deploy, and manage personalized patient journeys across brands and markets, complemented by therapy-specific branded Digital Drug Companions, a PATHWAYS web-based care coordination platform for providers, and an AI Voice Agent (VIA) for phone-based patient engagement.

The company generates revenue primarily through multi-year enterprise SaaS subscriptions with pharmaceutical companies for branded digital drug companion deployments, with pricing tied to deployment scope, number of brands, markets, and patient volume. The customer base includes 25+ pharma partners drawn from the top 20 global pharmaceutical companies across therapeutic areas including immunology, inflammatory conditions, mental health, metabolic/GLP-1, neurology, and oncology. A free consumer-facing Medisafe mobile app (4.7-star rating, 150K+ app-store reviews) functions as a freemium acquisition channel and distribution surface for pharma partner programs. Professional services revenue from implementation, configuration, and integration with pharma PSPs and hub services supplements the subscription base. Distribution combines direct enterprise field sales to pharma brand teams and procurement, white-label/OEM licensing through the Maestro SDK, and consumer self-serve app store downloads.

Medisafe's platform is validated through peer-reviewed research with IQVIA, Komodo Health, Vanderbilt University/NIH, and JMIR, and the company holds ISO 27001, ISO 13485 (enabling Software as a Medical Device positioning), HIPAA, SOC 2 Type II, GDPR, and 21 CFR Part 11 certifications. Strategic pharma co-development is anchored by partnerships with Eisai and Biogen on the PATHWAYS platform for Alzheimer's disease patient management, and the company maintains a strategic technology partnership with Amazon Web Services (AWS) for AI infrastructure. Institutional investors include ALIVE Israel HealthTech Fund (lead Series C, board seat), Sanofi Ventures (board seat), Pitango Venture Capital (board seat), Octopus Ventures, 7wire Ventures, Qualcomm Ventures, and M Ventures, with total disclosed funding of approximately $51.5M across rounds from 2012 through 2021.

Medisafe firmographics

Firmographics
Name
Medisafe
Legal name
Medisafe Project Ltd.
Website
https://medisafe.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Medisafe is an AI-driven patient engagement platform that helps pharmaceutical companies improve medication adherence through branded digital drug companions, predictive behavioral interventions, and provider care coordination tools, serving 25+ top-20 global pharma partners across 150+ countries.
Ownership category
akta.pro rank

Medisafe industry classification

Industry
Product category
Pharmaceutical Patient Engagement Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAHAD
Care Management & Coordination Platforms (case/disease management workflows)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Medication adherence software
  • Patient engagement platform
  • Digital therapeutics
  • Pharma patient support
  • Healthcare analytics

Where Medisafe is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Medisafe business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise SaaS Platform Licensing: Pharmaceutical companies license the Medisafe platform to deploy branded digital drug companions for their therapies. Pricing is based on deployment scope, number of brands, markets, and patient volume.
  2. Patient App (Freemium): Free medication management app for consumers with premium features available. The app serves as a distribution channel for pharma partner programs and generates indirect revenue through B2B relationships.
  3. Professional Services: Implementation, configuration, and customization services for pharma partners deploying branded experiences. Includes onboarding, integration with existing hub/PSP programs, and ongoing support.

Pricing tiers

ModelBillingPrice
FreemiumOthersPatient App - Free Tier
SubscriptionMulti-year contractEnterprise Pharma Platform
FreemiumOthersPATHWAYS for Healthcare Providers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Medisafe product offering

Product offering

Core offering

Medisafe operates a behavior-driven patient engagement platform combining the Medisafe Maestro enterprise orchestration suite, the JITI predictive AI engine, and therapy-specific Digital Drug Companions that pharmaceutical companies license to deploy branded patient support across brands and markets. The platform is complemented by a free consumer mobile app for medication management, the PATHWAYS web-based care coordination tool for healthcare providers, and an AI Voice Agent (VIA) for conversational patient outreach.

Product overview

Medisafe is a modular patient engagement platform architecture consisting of three core engines: Medisafe Maestro (enterprise orchestration platform for pharma teams), Digital Drug Companion (therapy-specific patient experiences), and JITI Predictive Engine (behavioral intelligence layer). The platform serves pharmaceutical companies, healthcare providers, and patients directly, offering solutions for Hub & PSP acceleration, drug launch support, portfolio-wide orchestration, and clinical trial support. Additional offerings include the Medisafe consumer app for medication management, AI Voice Agent (VIA) for conversational support, and PATHWAYS for provider care coordination. The platform is validated through IQVIA, Vanderbilt University, NIH, and Komodo Health research.

Differentiator

Problem solved

Functional benefit

Brands

  • JITI (Just-in-Time Intervention): Proprietary AI-driven behavioral prediction engine that identifies patient non-adherence risk and triggers personalized just-in-time interventions.
  • Medisafe Maestro
  • PATHWAYS
  • Medisafe VIA
  • Rapid Release

Products and services

  • Medisafe Maestro Enterprise orchestration platform serving as the command center for pharma patient engagement programs. Enables pharmaceutical brand teams to design, deploy, and manage personalized patient journeys across brands and markets without engineering resources, with visual journey builder, multi-brand/multi-market campaign management, real-time analytics, configurable intervention rules, and enterprise SSO/audit logging.
  • Digital Drug Companion Therapy-specific branded patient experiences that extend pharmaceutical support beyond the prescription, tailored to each therapy's adherence challenges, side-effect profile, and patient population. Includes personalized medication reminders, therapy-specific education, caregiver coordination, progress tracking, white-label branding, and omnichannel engagement across web, app, text, and voice.
  • JITI Predictive Engine Behavioral intelligence layer built on 12+ years of real-world patient data that uses machine learning to predict patient risk and trigger just-in-time interventions. Features predictive non-adherence risk scoring, intervention triggers based on 130+ behavioral signals per patient, personalization engine, continuous learning, and privacy-first architecture with de-identified behavioral models.
  • Medisafe App Free medication management mobile app helping millions of patients track medications, appointments, and measurements. Features smart reminders, drug interaction alerts, caregiver support via Medfriend, progress reports, and integration with Apple HealthKit, Samsung S-Health, and Google Fit.
  • PATHWAYS Web-based care coordination platform for healthcare providers, HCPs, infusion centers, and clinical teams managing patients on chronic and specialty therapies. Offers at-a-glance patient and disease care dashboards, multi-site care coordination, and care plan tracking, recognized as Best Care Coordination Platform in 2025 MedTech Breakthrough Awards.
  • Medisafe AI Voice Agent (VIA) Conversational AI voice agent that proactively engages patients via phone to log doses, check symptoms, and deliver personalized support. Extends reach across digital literacy levels and age groups, especially for populations less engaged with apps or digital interfaces.

Quantifiable outcome

  • 15% increase in medication adherence
  • +8 more outcomes

Companies that use Medisafe

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Medisafe technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature6 records

Medisafe partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and flagship.

  • Amazon Web Services (AWS)coreTechnology or IntegrationStrategic partnership announced in 2023 combining Medisafe's 10+ years of healthcare data and experience with AWS's AI capabilities to build the future of connected health with technology advancements and regulatory achievements.
  • EHR Systems (Integration)coreTechnology or IntegrationOpen APIs enable integration with Electronic Health Records, CRM systems, and pharma's existing digital infrastructures for seamless patient journeys and consistent brand experience.
  • EisaiflagshipStrategic or Co-development PartnerCo-developed PATHWAYS platform for Alzheimer's disease patient care coordination. Eisai and Biogen partnered with Medisafe to deploy the web-based tool for FDA-approved monoclonal antibody treatments.
  • BiogenflagshipStrategic or Co-development PartnerCo-developed PATHWAYS platform for Alzheimer's disease patient care coordination. PATHWAYS is recognized as Best Care Coordination Platform in 2025 MedTech Breakthrough Awards.
  • IQVIAcoreStrategic or Co-development PartnerResearch partnership conducting validation studies on medication adherence. IQVIA published peer-reviewed research demonstrating Medisafe's impact on HIV and hypertension patient adherence outcomes.
  • Komodo HealthcoreStrategic or Co-development PartnerHealthcare data partnership for real-world evidence. Komodo Health study of 1600 patients over 52 weeks demonstrated 22% incremental persistence lift and 2.1 additional Rxs per patient for Medisafe users.
  • Vanderbilt University / NIHcoreStrategic or Co-development PartnerAcademic research partnership contributing to NIH-published research validating Medisafe's platform efficacy and patient outcomes.

Scale indicators13 records

Recent moves6 records

Expansion highlights3 records

Medisafe competitors and assessment

Company assessment

Direct peers

  • Welldoc: Digital health platform focused on chronic disease management with FDA-cleared SaMD products and pharma partnerships (e.g., AstraZeneca). Operates a similar B2B2C model serving payers, providers, and pharma — directly comparable to Medisafe's Maestro + JITI architecture.
  • Click Therapeutics: Prescription digital therapeutics company with pharma partnerships (Otsuka for depression adjunct, Boehringer Ingelheim). Pursues the same enterprise pharma licensing model and FDA-regulated digital therapeutic pathway that Medisafe targets via ISO 13485 SaMD positioning.
  • AdhereHealth: Medication adherence management platform combining predictive analytics with human outreach for payers, health systems, and pharma. Competes with Medisafe on the payer-sponsored adherence layer and predictive non-adherence risk scoring use case.
  • RxAnte: Medication adherence analytics platform using predictive models to identify at-risk patients for payers and PBMs. Overlaps with Medisafe's JITI predictive engine and pharma/payer GTM motion.
  • emocha Health: Digital medication adherence platform featuring directly observed therapy via video and asynchronous chat. Competes with Medisafe's patient engagement offering, particularly in public health, infectious disease, and specialty therapy adherence.
  • OptimizeRx: Provider-patient engagement and messaging platform that connects pharma brand messaging into the EHR workflow. Targets the same pharma brand team buyers as Medisafe and represents a competing approach to in-workflow digital engagement.
  • Akili Interactive: Digital therapeutics company with FDA-cleared prescription cognitive treatments, monetized via consumer subscription and potential pharma channels. Operates in the adjacent digital therapeutics category with the same pharma-licensing thesis.

Emerging players

  • Virta Health: Digital health company focused on metabolic disease reversal (type 2 diabetes, prediabetes) with strong outcomes evidence and payer/employer contracts. Overlaps with Medisafe in the metabolic/GLP-1 therapeutic area and chronic-condition patient engagement.
  • Omada Health: Virtual-first chronic care platform for diabetes, hypertension, and mental health sold primarily to employers and payers. Overlaps with Medisafe in chronic-condition management and GLP-1/musculoskeletal therapeutic engagement.

Broad incumbents

  • Veeva Systems: Pharma commercial cloud platform offering CRM, content management, and patient engagement modules. Represents the larger incumbent that pharma procurement may consolidate toward, potentially squeezing specialized vendors like Medisafe into narrower niches.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Medisafe social profiles

Digital presence

Medisafe compliance and trust

Trust signal

Compliance6 records

Medisafe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medisafe leadership team

Management profile

Number of profiles

Profiles3 records

Medisafe funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medisafe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medisafe

What does Medisafe do?

Medisafe operates a behavior-driven patient engagement platform combining the Medisafe Maestro enterprise orchestration suite, the JITI predictive AI engine, and therapy-specific Digital Drug Companions that pharmaceutical companies license to deploy branded patient support across brands and markets. The platform is complemented by a free consumer mobile app for medication management, the PATHWAYS web-based care coordination tool for healthcare providers, and an AI Voice Agent (VIA) for conversational patient outreach.

Is Medisafe a public or private company?

Medisafe is a private company. It is classified as venture growth investor backed and is currently operating.

When was Medisafe founded?

Medisafe was founded in 2012. It employs 51 to 100 people.

Where is Medisafe based?

Medisafe is headquartered in Boston, United States, in the North America region.

How does Medisafe make money?

Three revenue lines are on record. Enterprise SaaS Platform Licensing is the primary driver. The others are patient App (Freemium) and professional Services.

Who are Medisafe's main competitors?

Direct peers on record are Welldoc, Click Therapeutics, AdhereHealth, RxAnte, emocha Health, OptimizeRx and Akili Interactive. Emerging players are Virta Health and Omada Health. Veeva Systems is listed as a broad incumbent.

Does Medisafe have an API?

No public API is recorded for Medisafe.

What industry is Medisafe in?

Medisafe's product category is Pharmaceutical Patient Engagement Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WIREDApps for Caregivers Get a Dose of AI, but That Might Not Be EnoughCaregiver apps like Medisafe, Caring Village, Mejo, and Ari use AI to track medications, appointments, and symptoms, but experts warn they lack FDA review and HIPAA protection. The apps aim to reduce caregiver burden, yet experts say a broader solution requires government, private, and family involvement.The Manila TimesAssistRx and Medisafe Unite to Power Smarter, More Connected Patient EngagementAssistRx, an advanced therapy initiation and patient solutions provider, announced a partnership with Medisafe, a medication engagement platform serving over 13 million patients worldwide, to enhance its patient engagement solutions with a new user interface. The collaboration integrates Medisafe's intelligent patient engagement engine with AssistRx's Advanced eServices suite, enabling real-time status updates across benefits verification, prior authorization, therapy delivery, and long-term adherence. The partnership aims to improve patient conversion rates, reduce drop-off, and deliver personalized interventions through a single orchestration layer for life sciences organizations.GlobeNewswireAssistRx and Medisafe Unite to Power Smarter, More Connected Patient EngagementAssistRx announced a partnership with Medisafe to add a patient engagement user interface powered by Medisafe's platform. The collaboration aims to improve patient conversion and reduce drop-off across therapy initiation. The solution integrates with AssistRx's Advanced eServices suite.Caringvillage11 Best Caregiver Apps for Families (2026)The article reviews 11 caregiver applications for families in 2026, highlighting tools for medication tracking, shared calendars, emergency alerts, and care management. It positions Caring Village as a comprehensive coordination hub while detailing specific functionalities of competitors like Medisafe, CaringBridge, and Ianacare. The guide provides strategic advice on selecting apps based on family needs and offers a 72-hour onboarding plan to ensure user adoption.IntuitionLabsPharmaceutical Mobile App Usage and Engagement StrategiesThis comprehensive industry report examines how pharmaceutical companies leverage mobile apps for patient engagement, adherence support, and marketing under the "beyond the pill" strategy, covering engagement techniques such as gamification, personalization, and wearable integration. The report analyzes case studies including MySugr (Roche), Propeller Health (ResMed), Click Therapeutics, and Medisafe, while addressing key challenges including regulatory hurdles, data privacy concerns, and the commercial viability struggles that led to failures like Pear Therapeutics' bankruptcy in 2023. Future innovations are expected to focus on AI-driven personalization, wearable integration, and digital therapeutics, though reimbursement pathways remain a critical bottleneck for sustainable business models in this space.MedisafePatient Engagement Platform for PharmaMedisafe provides a behavior-driven digital engagement platform designed to help pharmaceutical brands activate patients and improve treatment outcomes. The solution extends patient support programs into daily life through digital tools that reinforce medication use and therapy adherence.SolguruzAI in Eldercare: 6 Top Use Cases for Elder Care App DevelopmentSolGuruz outlines six key applications of artificial intelligence in eldercare, including health monitoring, medication management, and fall detection, to address a market projected to reach $1.1 trillion by 2028. The article highlights specific AI-driven solutions such as MyChart, Medisafe, and CareCompanion that aim to improve senior safety and independence. It serves as a promotional piece for SolGuruz's custom software development services in the healthcare sector.SpacecoastdailyTop Platforms and Apps to Help Seniors Maintain a Healthy LifestyleSix apps and platforms are presented to help seniors maintain a healthy lifestyle, including SilverSneakers GO for fitness, Calm for mindfulness, Wellth for habit rewards, MyFitnessPal for nutrition, Fitbit for activity tracking, and Medisafe for medication management. Each app offers user-friendly tools tailored to seniors' needs, covering exercise, mental health, nutrition, and medication adherence.GlobeNewswireMedisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards ProgramMedisafe's PATHWAYS, a care coordination platform for Alzheimer's treatment, won Best Care Coordination Platform in the 9th MedTech Breakthrough Awards. The tool, developed with Eisai and Biogen, tracks dosing and monitoring for FDA-approved monoclonal antibodies. The company plans to use the award to further its patient engagement mission.YahooMedisafe PATHWAYS, Eisai and Biogen Recognized for Alzheimer’s Disease Innovation in 2025 MedTech Breakthrough Awards ProgramMedisafe's PATHWAYS, a collaboration with Eisai and Biogen, won the Best Care Coordination Platform award in the 9th annual MedTech Breakthrough Awards. The tool streamlines patient tracking and care coordination for Alzheimer's treatment, including dosing and monitoring. The company plans to use the recognition to further its mission of empowering patients.